Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 6
2004 6
2005 5
2006 4
2007 2
2008 2
2009 4
2010 11
2011 10
2012 12
2013 6
2014 5
2015 10
2016 8
2017 8
2018 9
2019 5
2020 3
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

103 results
Results by year
Filters applied: . Clear all
Page 1
Genetics and Therapies for GM2 Gangliosidosis.
Cachon-Gonzalez MB, Zaccariotto E, Cox TM. Cachon-Gonzalez MB, et al. Curr Gene Ther. 2018;18(2):68-89. doi: 10.2174/1566523218666180404162622. Curr Gene Ther. 2018. PMID: 29618308 Free PMC article. Review.
Gaucher Disease in Bone: From Pathophysiology to Practice.
Hughes D, Mikosch P, Belmatoug N, Carubbi F, Cox T, Goker-Alpan O, Kindmark A, Mistry P, Poll L, Weinreb N, Deegan P. Hughes D, et al. J Bone Miner Res. 2019 Jun;34(6):996-1013. doi: 10.1002/jbmr.3734. Epub 2019 Jun 24. J Bone Miner Res. 2019. PMID: 31233632 Free PMC article. Review.
Sale JE, Cox TM. Sale JE, et al. Among authors: cox tm. Expert Rev Mol Med. 2016 May 10;18:e10. doi: 10.1017/erm.2016.10. Expert Rev Mol Med. 2016. PMID: 27160347 No abstract available.
Therapeutic goals in the treatment of Gaucher disease.
Pastores GM, Weinreb NJ, Aerts H, Andria G, Cox TM, Giralt M, Grabowski GA, Mistry PK, Tylki-Szymańska A. Pastores GM, et al. Among authors: cox tm. Semin Hematol. 2004 Oct;41(4 Suppl 5):4-14. doi: 10.1053/j.seminhematol.2004.07.009. Semin Hematol. 2004. PMID: 15468045 Review.
Innovative treatments for lysosomal diseases.
Cox TM. Cox TM. Best Pract Res Clin Endocrinol Metab. 2015 Mar;29(2):275-311. doi: 10.1016/j.beem.2015.01.001. Epub 2015 Jan 24. Best Pract Res Clin Endocrinol Metab. 2015. PMID: 25987179 Review.
Emerging therapeutic targets for Gaucher disease.
Vitner EB, Vardi A, Cox TM, Futerman AH. Vitner EB, et al. Among authors: cox tm. Expert Opin Ther Targets. 2015 Mar;19(3):321-34. doi: 10.1517/14728222.2014.981530. Epub 2014 Nov 21. Expert Opin Ther Targets. 2015. PMID: 25416676 Review.
Therapeutic position of eliglustat.
Cox TM, Mistry PK. Cox TM, et al. Blood Cells Mol Dis. 2018 Mar;69:117-118. doi: 10.1016/j.bcmd.2017.11.001. Epub 2017 Nov 22. Blood Cells Mol Dis. 2018. PMID: 29187290 No abstract available.
Brexit and rare diseases: big risk, bigger opportunity?
Hyry HI, Cox TM, Roos JC. Hyry HI, et al. Among authors: cox tm. Curr Med Res Opin. 2017 Apr;33(4):783-784. doi: 10.1080/03007995.2017.1284053. Epub 2017 Mar 9. Curr Med Res Opin. 2017. PMID: 28100081
103 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page